InvestorsHub Logo
icon url

nidan7500

11/14/21 9:03 AM

#335939 RE: plexrec #335937

plex" Anavex fragile X syndrome clinical trial should be illuminating; "--optimistic here--2-73 will be helpful for a broad range of CNS conditions



Agree, we are about to (soon) witness what is behind the curtain of CNS diseases. Many will benefit directly as stock holders but most will benefit from the indirect spread of treatment knowledge. Life can be tough and short for some who have some CNS disorder while the QOL for the rest of us is shadowed by related unknown-unknowns. This is bigger than simply helping the direct CNS patients and their families.

IMO, if-when we start to peel back the medical-clinical CNS treatment onion we will begin to understand better how profoundly wrong and weak our current treatment systems are . We will know it when we finally see it, all very positive.

Glad I do not know-see-or understand what Dr.M. and staff must see. Most of us are just along for the ride.